Lv1
30 积分 2023-02-24 加入
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy /- chemotherapy in nonsquamous non-small cell lung cancer
1个月前
已完结
[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor]
1个月前
已完结
[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor]
2个月前
已完结
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas
3个月前
已完结
Prognostic value ofKRASmutations,TP53mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
3个月前
已完结
[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion]
3个月前
已完结
Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology‐proven malignant pleural effusions
3个月前
已完结
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
3个月前
已完结
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
3个月前
已完结
皖公网安备34019202002308
